Shoichiro Tsuji
Overview
Explore the profile of Shoichiro Tsuji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuji S, Kuramoto Y, Rajbhandari S, Takeda Y, Yamahara K, Yoshimura S
Front Cell Dev Biol
. 2024 Sep;
12:1464727.
PMID: 39324071
Introduction: Spinal cord injury (SCI) leads to severe disabilities and remains a significant social and economic challenge. Despite advances in medical research, there are still no effective treatments for SCI....
2.
Kuramoto Y, Taira T, Tsuji S, Yoshimura S
Cureus
. 2024 Sep;
16(8):e67064.
PMID: 39290919
Background Meige syndrome is a segmental dystonia affecting the head and neck, with bilateral blepharospasm as the primary symptom. First-line treatment typically involves Botox injections. For cases resistant to this...
3.
Marani W, Montemurro N, Tsuji S, Perrini P, Noda K, Ota N, et al.
Neurosurg Focus Video
. 2022 Oct;
4(1):V13.
PMID: 36284621
Cerebellar arteriovenous malformations (AVMs) represent 10%-15% of all intracranial AVMs and are associated with a greater risk for hemorrhagic presentation compared with supratentorial AVMs. When they reach the cerebellopontine angle...
4.
Marani W, Mannara F, Noda K, Kondo T, Ota N, Perrini P, et al.
Oper Neurosurg (Hagerstown)
. 2021 Apr;
21(2):E124-E125.
PMID: 33861341
Despite technological advances in endovascular therapy, surgical clipping of paraclinoid aneurysms remains an indispensable treatment option and has an acceptable profile risk. Intraoperative monitoring of motor and somatosensory evoked potentials...
5.
Tsuji S, Stein L, Kamada N, Nunez G, Bram R, Vallance B, et al.
J Clin Invest
. 2014 Oct;
124(11):4857-66.
PMID: 25271628
The transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) controls differentiation of long-lived plasma cells, and almost 10% of individuals with common variable immunodeficiency (CVID) express either the C104R or...
6.
Tsuji S, Cortesao C, Bram R, Platt J, Cascalho M
Blood
. 2011 Oct;
118(22):5832-9.
PMID: 21984806
Deficiencies in transmembrane activator and CAML interactor (TACI) result in common variable immune deficiency, a syndrome marked by recurrent infections with encapsulated microorganisms, impaired production of antibodies, and lymphoproliferation. How...
7.
Fernandez-Zapico M, Lomberk G, Tsuji S, DeMars C, Bardsley M, Lin Y, et al.
Biochem J
. 2010 Dec;
435(2):529-37.
PMID: 21171965
SP/KLF (Specificity protein/Krüppel-like factor) transcription factors comprise an emerging group of proteins that may behave as tumour suppressors. Incidentally, many cancers that display alterations in certain KLF proteins are also...
8.
Platt J, Tsuji S, Cascalho M
Curr Opin Organ Transplant
. 2010 Dec;
16(1):61-8.
PMID: 21150607
Purpose Of Review: This manuscript reviews current knowledge and recent findings regarding antibody-independent functions of B cells in transplantation. Recent Findings: Until recently the functions of B cells in transplantation...
9.
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, et al.
Clin Cancer Res
. 2004 Jun;
10(12 Pt 1):4125-33.
PMID: 15217949
Purpose: Loss of intercellular adhesion and increased cell motility promote tumor cell invasion. In the present study, E- and N-cadherin, members of the classical cadherin family, are investigated as inducers...
10.
Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan S, Nakajima S, et al.
Int J Cancer
. 2003 Jun;
106(1):17-25.
PMID: 12794752
Many cancers are resistant to Fas-mediated apoptosis despite the expression of Fas. To investigate the mechanisms by which Fas signals are attenuated, we focused on decoy receptor 3 (DcR3). DcR3...